Exchange: OTC·Updated 10:33 AM EDT

BIOYF BioSyent Inc.

$11.27
$0.0325
(0.29%)
Today
EarningsNov 19
Mkt Cap$127.45M
Vol1,412.00

About BIOYF

BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include Cathejell Jelly, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada.
50

Neutral Sentiment

How do you feel about BIOYF?

Advertisement|Remove ads.